<DOC>
<DOCNO>
EP-0004835
</DOCNO>
<TEXT>
<DATE>
19791017
</DATE>
<IPC-CLASSIFICATIONS>
C07C-91/34 A61P-25/02 C07C-51/367 C07C-219/30 A61P-11/00 C07C-41/00 C07C-213/00 C07C-45/63 C07C-49/86 C07C-93/26 C07C-45/00 A61K-31/135 C07C-45/28 A61P-13/02 A61K-31/137 C07C-45/62 C07C-215/00 C07C-43/225 C07C-217/00 <main>C07C-93/14</main> A61P-13/00 C07C-67/00 C07C-51/347 C07C-215/60 C07C-43/00 A61K-31/215 C07C-41/26 C07C-219/00 C07C-217/56 C07C-49/00 A61P-15/00 A61P-25/00 C07C-217/70 A61P-11/08 C07C-217/62 C07C-45/74 C07C-49/255 A61K-31/21 
</IPC-CLASSIFICATIONS>
<TITLE>
ethanolamine compounds, processes for their preparation, pharmaceutical preparations containing them and their medicinal use.
</TITLE>
<APPLICANT>
draco abse<sep>aktiebolaget draco<sep>aktiebolaget dracofacks-221 01 lund 1se<sep>aktiebolaget draco  <sep>
</APPLICANT>
<INVENTOR>
olsson otto agne torsten<sep>persson nils henry alfons<sep>svensson leif ake<sep>waldeck carl bertil<sep>wetterlin kjell ingvar leopold<sep>olsson, otto agne torsten<sep>persson, nils henry alfons<sep>svensson, leif ake<sep>waldeck, carl bertil<sep>wetterlin, kjell ingvar leopold<sep>olsson, otto agne torstenhjortgatan 3s-223 50 lundse<sep>persson, nils henry alfonslanggatan 3s-240 10 dalbyse<sep>svensson, leif akestangby 17s-225 90 lundse<sep>waldeck, carl bertilsofielundsvägen 34s-240 17 s. sandbyse<sep>wetterlin, kjell ingvar leopoldvästervang 19s-240 17 s.sandbyse<sep>olsson, otto agne torsten<sep>persson, nils henry alfons<sep>svensson, leif ake<sep>waldeck, carl bertil<sep>wetterlin, kjell ingvar leopold<sep>olsson, otto agne torstenhjortgatan 3s-223 50 lundse<sep>persson, nils henry alfonslanggatan 3s-240 10 dalbyse<sep>svensson, leif akestangby 17s-225 90 lundse<sep>waldeck, carl bertilsofielundsvägen 34s-240 17 s. sandbyse<sep>wetterlin, kjell ingvar leopoldvästervang 19s-240 17 s.sandbyse<sep>
</INVENTOR>
<ABSTRACT>
compounds of the formula    and therapeutically acceptable salts thereof, in which formula  n is 1, 2 or 3; r¹ is selected from the group consisting of h,  aliphatic acyl groups containing 2 to 5 carbon atoms, and  unsubstituted or substituted benzoyl of the formula    wherein r³ is selected from the group consisting of hydrogen  and methyl; and wherein r² is selected from the group  consisting of h, aliphatic alkyl groups containing 1-4 carbon  atoms, benzyl, aliphatic acyl groups containing 2-5 carbon  atoms, and unsubstituted or substituted benzoyl of the  formula    wherein r⁴ is selected from the group consisting of hydrogen  and methyl; pharmaceutical preparations containing  an effective amount of such compounds, and the medicinal  use of the compounds.  
</ABSTRACT>
</TEXT>
</DOC>
